This infographic describes the FDA drug approval process.
A Brief Guide to the FDA Drug Approval Process
Posted by lifescienceswebinars in
Accel-Account Manager, Adverse Event Signal Detection, Adverse Event Signal Management, Analyzing Clinical Trial Data, Argus, Argus Safety, Argus Safety Database, Argus Safety Suite, ASCEND CTMS, Clinical Data, Clinical Data Analytics, Clinical Data Management System, Clinical Data Warehousing, Clinical Trial Data, Clinical Trial Data Analysis, Clinical Trial Data Regulatory Submissions, Clinical Trial Data Reporting, Clinical Trial Management System, clinical trial software, Clinical Trial Supply Tracking, clinical trial systems, Clinical Trials Data, CTMS, Drug Approval Process, Drug Safety, Drug Safety Database, drug safety software, Drug Safety System, EDC, EDMS, Electronic Data Capture, electronic document management system, Empirica Signal, Empirica Topics, FDA Drug Approval Process, iHelp, LabPas, Life Sciences Data Hub, Oracle Argus, Oracle Argus Safety, Oracle CDA, Oracle Clinical, Oracle Clinical Account Management, Oracle Empirica, Oracle Empirica Topics, Oracle Health Sciences LabPas, Oracle LabPas, Oracle Life Sciences Data Hub, Oracle LSH, Oracle RDC, Oracle RDC Account Management, Oracle Remote Data Capture, Oracle Siebel Clinical Trial Management System, Oracle Thesaurus Management System, Oracle TMS, Oracle TMS Account Management, Pharmacovigilance, Pharmacovigilance software, Pharmacovigilance System, Phase 1 Clinic Automation System, Phase 1 clinical trial software, Phase Forward Empirica, Remote Data Capture, Risk Management, Siebel Clinical, Siebel Clinical Trial Management System, Siebel CTMS, Signal Detection, Signal Management
and tagged with clinical, clinical data analytics, clinical data warehouse, clinical trial management system, drug approval process, drug safety, FDA, fda approval process, fda drug approval process, IND application, NDA, Oracle, oracle health sciences, pharmacovigilance, pharmacovigilance system, phase 1 clinical trial, phase II clinical trial, phase III clinical trial, phase IV clinical trials, pre-clinical, signal management